Apolipoprotein E protects cultured pericytes and astrocytes from D-Aβ1-40-mediated cell death

Brain Research

Volumn 1315, Issue , 2010, Pages 169-180

  Bruinsma, Ilona B ^a   Wilhelmus, Micha M M ^a,b   Kox, Matthijs ^a   Veerhuis, Robert ^b   de Waal, Robert M W ^a   Verbeek, Marcel M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Accumulation; Amyloid with Dutch mutation; Apolipoprotein E; Cytotoxicity; Internalization

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN; CELL CULTURE; CELL DEATH; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; GENOTYPE; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; PERICYTE; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASTROCYTES; BRAIN; CELL DEATH; CELL MEMBRANE; CELLS, CULTURED; CEREBRAL AMYLOID ANGIOPATHY; CULTURE MEDIA, CONDITIONED; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEPTIDE FRAGMENTS; PERICYTES; RECOMBINANT PROTEINS;

EID: 75549089646     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.039     Document Type: Article

References (61)

1. Arelin K., Kinoshita A., Whelan C.M., Irizarry M.C., Rebeck G.W., Strickland D.K., and Hyman B.T. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Brain Res. Mol. Brain Res. 104 (2002) 38-46
2. Bales K.R., Liu F., Wu S., Lin S., Koger D., DeLong C., Hansen J.C., Sullivan P.M., and Paul S.M. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29 (2009) 6771-6779
3. Bertrand P., Poirier J., Oda T., Finch C.E., and Pasinetti G.M. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res. Mol. Brain Res. 33 (1995) 174-178
4. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., and Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest 76 (1985) 1501-1513
5. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 82 (1991) 239-259
6. Brera B., Serrano A., and de Ceballos M.L. Beta-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress. Neurobiol. Dis. 7 (2000) 395-405
7. Castano E.M., Prelli F., Wisniewski T., Golabek A., Kumar R.A., Soto C., and Frangione B. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem. J. 306 Pt 2 (1995) 599-604
8. Champagne D., Pearson D., Dea D., Rochford J., and Poirier J. The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease. Neuroscience 121 (2003) 99-110
9. Davis J., and Van Nostrand W.E. Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2996-3000
10. Davis-Salinas J., Saporito-Irwin S.M., Cotman C.W., and Van Nostrand W.E. Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65 (1995) 931-934
11. Davis-Salinas J., Saporito-Irwin S.M., Donovan F.M., Cunningham D.D., and Van Nostrand W.E. Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid beta-protein precursor. J. Biol. Chem. 269 (1994) 22623-22627
12. de Groot C.J., Langeveld C.H., Jongenelen C.A., Montagne L., Van V D., and Dijkstra C.D. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J. Neurosci. Res. 49 (1997) 342-354
13. Dekroon R.M., and Armati P.J. Synthesis and processing of apolipoprotein E in human brain cultures. Glia 33 (2001) 298-305
14. DeMattos R.B., Brendza R.P., Heuser J.E., Kierson M., Cirrito J.R., Fryer J., Sullivan P.M., Fagan A.M., Han X., and Holtzman D.M. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 39 (2001) 415-425
15. DeMattos R.B., Rudel L.L., and Williams D.L. Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. J. Lipid Res. 42 (2001) 976-987
16. Drouet B., Fifre A., Pinçon-Raymond M., Vandekerckhove J., Rosseneu M., Guéant J., Chambaz J., and Pillot T. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-β peptide. J. Neurochem. 76 (2001) 117-127
17. Egorina E.M., Sovershaev M.A., Bjorkoy G., Gruber F.X., Olsen J.O., Parhami-Seren B., Mann K.G., and Osterud B. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1493-1498
18. Farhangrazi Z.S., Ying H., Bu G., Dugan L.L., Fagan A.M., Choi D.W., and Holtzman D.M. High density lipoprotein decreases beta-amyloid toxicity in cortical cell culture. Neuroreport 8 (1997) 1127-1130
19. Folin M., Baiguera S., Guidolin D., Di L.R., Grandi C., De C.E., Nussdorfer G.G., and Parnigotto P.P. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner. Int. J. Mol. Med. 17 (2006) 821-826
20. Gylys K.H., Fein J.A., Tan A.M., and Cole G.M. Apolipoprotein E enhance uptake of soluble but not aggregated amyloid-β into synaptic terminals. J. Neurochem. 84 (2003) 1442-1451
21. Harris F.M., Tesseur I., Brecht W.J., Xu Q., Mullendorff K., Chang S., Wyss-Coray T., Mahley R.W., and Huang Y. Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J. Biol. Chem. 279 (2004) 3862-3868
22. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31 (1990) 545-548
23. Jiang Q., Lee C.Y., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., Mann K., Lamb B., Willson T.M., Collins J.L., Richardson J.C., Smith J.D., Comery T.A., Riddell D., Holtzman D.M., Tontonoz P., and Landreth G.E. ApoE promotes the proteolytic degradation of Abeta. Neuron 58 (2008) 681-693
24. Koistinaho M., Lin S., Wu X., Esterman M., Koger D., Hanson J., Higgs R., Liu F., Malkani S., Bales K.R., and Paul S.M. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10 (2004) 719-726
25. Leal M.C., Dorfman V.B., Gamba A.F., Frangione B., Wisniewski T., Castano E.M., Sigurdsson E.M., and Morelli L. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology. J. Neuropathol. Exp. Neurol. 65 (2006) 976-987
26. Legleiter J., DeMattos R.B., Holtzman D.M., and Kowalewski T. In situ AFM studies of astrocyte-secreted apolipoprotein E- and J-containing lipoproteins. J. Colloid Interface Sci. 278 (2004) 96-106
27. Ma J., Yee A., Brewer Jr. H.B., Das S., and Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372 (1994) 92-94
28. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
29. Manelli A.M., Bulfinch L.C., Sullivan P.M., and Ladu M.J. Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation. Neurobiol. Aging 28 (2006) 1139-1147
30. Matrone C., Di L.A., Meli G., D'Aguanno S., Severini C., Ciotti M.T., Cattaneo A., and Calissano P. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J. Alzheimers Dis. 13 (2008) 81-96
31. Miyata M., and Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14 (1996) 55-61
32. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541 (1991) 163-166
33. Nielsen H.M., Veerhuis R., Holmqvist B., and Janciauskiene S. Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 57 (2009) 978-988
34. Nilsson L.N., Arendash G.W., Leighty R.E., Costa D.A., Low M.A., Garcia M.F., Cracciolo J.R., Rojiani A., Wu X., Bales K.R., Paul S.M., and Potter H. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiol. Aging 25 (2004) 1153-1167
35. Peters-Libeu C.A., Newhouse Y., Hatters D.M., and Weisgraber K.H. Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J. Biol. Chem. 281 (2006) 1073-1079
36. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., and Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13 (1993) 1676-1687
37. Poirier J., Hess M., May P.C., and Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res. Mol. Brain Res. 11 (1991) 97-106
38. Prior R., Wihl G., and Urmoneit B. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance. Ann. N.Y. Acad. Sci. 903 (2000) 180-186
39. Rensink A.A., Otte-Holler I., de B.R., Bosch R.R., ten Donkelaar H.J., de Waal R.M., Verbeek M.M., and Kremer B. Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes. Neurobiol. Aging 25 (2004) 93-103
40. Rensink A.A., Verbeek M.M., Otte-Holler I., ten Donkelaar H.T., de Waal R.M., and Kremer B. Inhibition of amyloid-beta-induced cell death in human brain pericytes in vitro. Brain Res. 952 (2002) 111-121
41. Riddell D.R., Zhou H., Atchison K., Warwick H.K., Atkinson P.J., Jefferson J., Xu L., Aschmies S., Kirksey Y., Hu Y., Wagner E., Parratt A., Xu J., Li Z., Zaleska M.M., Jacobsen J.S., Pangalos M.N., and Reinhart P.H. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J. Neurosci. 28 (2008) 11445-11453
42. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., and Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
43. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
44. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., and Zlokovic B.V. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106 (2000) 1489-1499
45. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A 90 (1993) 1977-1981
46. Urmoneit B., Prikulis I., Wihl G., D'Urso D., Frank R., Heeren J., Beisiegel U., and Prior R. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 77 (1997) 157-166
47. van Duinen S.G., Castano E.M., Prelli F., Bots G.T., Luyendijk W., and Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A 84 (1987) 5991-5994
48. Van Nostrand W.E., Melchor J.P., and Ruffini L. Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J. Neurochem. 70 (1998) 216-223
49. Veerhuis R., Janssen I., Hoozemans J.J., de Groot C.J., Hack C.E., and Eikelenboom P. Complement C1-inhibitor expression in Alzheimer's disease. Acta Neuropathol. (Berl) 96 (1998) 287-296
50. Verbeek M.M., de Waal R.M., Schipper J.J., and Van Nostrand W.E. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J. Neurochem. 68 (1997) 1135-1141
51. Verbeek M.M., Otte-Holler I., Wesseling P., Ruiter D.J., and de Waal R.M. Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am. J. Pathol. 144 (1994) 372-382
52. Verbeek M.M., Van Nostrand W.E., Otte-Holler I., Wesseling P., and de Waal R.M. Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype. Ann. N.Y. Acad. Sci. 903 (2000) 187-199
53. Wenham P.R., Price W.H., and Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 337 (1991) 1158-1159
54. White A.R., Zheng H., Galatis D., Maher F., Hesse L., Multhaup G., Beyreuther K., Masters C.L., and Cappai R. Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress. J. Neurosci. 18 (1998) 6207-6217
55. Wilhelmus M.M., Otte-Holler I., Davis J., Van Nostrand W.E., de Waal R.M., and Verbeek M.M. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. J. Neurosci. 25 (2005) 3621-3627
56. Wilhelmus M.M., Boelens W.C., Otte-Holler I., Kamps B., Kusters B., Maat-Schieman M.L., de Waal R.M., and Verbeek M.M. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity. Acta Neuropathol. (Berl) 111 (2006) 139-149
57. Wilhelmus M.M., Otte-Holler I., van Triel J.J., Veerhuis R., Maat-Schieman M.L., Bu G., de Waal R.M., and Verbeek M.M. Lipoprotein receptor-related protein-1 mediates amyloid-{beta}-mediated cell death of cerebrovascular cells. Am. J. Pathol. 171 (2007) 1989-1999
58. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C., and Husemann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9 (2003) 453-457
59. Xu Q., Bernardo A., Walker D., Kanegawa T., Mahley R.W., and Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26 (2006) 4985-4994
60. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., Xu J., Hsu C.Y., Mills J.C., Holtzman D.M., and Lee J.M. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 26 (2006) 10939-10948
61. Zlokovic B.V. Clearing amyloid through the blood-brain barrier. J. Neurochem. 89 (2004) 807-811